Cancer Advances
Subscribe:
Featured Episode
Rethinking "More Is Better": Deescalating Cancer Care
As cancer care becomes increasingly personalized, treatment deescalation is emerging as a key strategy to balance efficacy with quality of life. In this episode of Cancer Advances, Jame Abraham, MD, Enterprise Chair of Hematology and Medical Oncology at Cleveland Clinic, discusses how clinicians are rethinking dose intensity, duration and therapeutic selection across disease settings. Learn how evolving evidence, patient preferences and emerging technologies like AI are shaping treatment decisions and redefining standards of care.
Play NowAll Cancer Advances Episodes
May 21, 2026
Using Dynamic Models to Inform Treatment and Prognosis in AML
How can we better predict progression and outcomes in a disease where treatment decisions must be made in days, sometimes hours? In this episode of Cancer Advances, Moaath Mustafa Ali, MD, MPH, discusses emerging longitudinal and evolutionary modeling approaches that integrate clinical, genomic and treatment data over time to improve risk stratification in acute myeloid leukemia. Learn how these models may support earlier, more informed decisions around therapy selection, relapse risk and long-term management.
Play NowMay 14, 2026
Preserving Fertility During Pelvic Radiation: A Multidisciplinary Surgical Approach
Young patients requiring pelvic radiation face limited fertility preservation options. In this episode of Cancer Advances, Robert DeBernardo, MD, and Johanna Kelley, MD, both gynecologic oncologists at Cleveland Clinic, discuss uterine transposition—a novel surgical approach that protects both ovarian function and the uterus—using a real world rectal cancer case. Learn which patients may benefit, how the multidisciplinary model works and what this technique could mean for counseling, referrals and long term reproductive outcomes.
Play NowMay 7, 2026
Optimizing Treatment Decisions in Muscle-Invasive Bladder Cancer
Shilpa Gupta, MD, Genitourinary Medical Oncologist, joins the Cancer Advances podcast to explore how perioperative immunotherapy and ctDNA are redefining management of muscle-invasive bladder cancer. She reviews emerging phase III data and explains how it can inform treatment selection, referral timing and adjuvant decision making in clinical practice.
Play NowApril 30, 2026
20 Years of Multidisciplinary Collaboration: Lessons from the Spine Tumor Board
Lilyana Angelov, MD, Neurosurgeon and Director of the Cleveland Clinic Gamma Knife Center, Samuel Chao, MD, Radiation Oncologist and Associate Director of the Gamma Knife Center; and Ajit Krishnaney, MD, Neurosurgeon in the Center for Spine Health, join the Cancer Advances podcast to share insights from 20 years of a multidisciplinary spine tumor board. Learn how multidisciplinary strategies and newer technologies are improving decision-making, local control and patient outcomes.
Play Now
